The impact of smoke-free prisons in Scotland
Case study on research into the impact of smoke free prisons
- Published: 25 October 2020
Case studies
Latest case studies
Filter results
Latest case studies
Surviving sepsis - is this the answer?
New drug helps medical teams make the best decisions to manage critically ill patients.
- Published: 20 October 2020
REMAP-CAP tests treatments for COVID-19
Story of a nationally-prioritised study which aims to provide answers about the best treatment options for COVID-19 patients who develop pneumonia.
- Published: 18 September 2020
The invaluable role of patients and the public in health research
The MOAM trial provides an excellent demonstration of the impact of patient and public involvement in research.
- Published: 17 September 2020
Infections in childbirth and antibiotic use
Childbirth infection halved through single dose of antibiotics
- Published: 14 September 2020
Empowering individuals to take action against type 2 diabetes
Case study on research into the effects of a liquid diet on type 2 diabetes
- Published: 11 September 2020
Childhood respiratory virus diagnosis without delay
Results from recent trials could change care pathways in the future diagnosis of respiratory virus infection in children.
- Published: 17 August 2020
Pneumococcal vaccination of children
The pneumococcal vaccine schedule changed after a NIHR-funded trial demonstrated that fewer injections can deliver immunity in the UK.
- Published: 04 August 2020
Digital test provides quick and clear data for ADHD diagnosis
Case study on research into test for ADHD
- Published: 29 April 2020
Chipping away at portion sizes
NIHR School for Public Health Research explored how working with a wholesale supplier could encourage fish and chip shops to offer smaller portion sizes.
- Published: 19 August 2019
Hope for stroke patients with aphasia
NIHR researchers compare self-managed computer therapy programme to usual speech and language therapy.
- Published: 01 July 2019
Cheaper macular degeneration drug could save NHS millions
Avastin, a drug that treats neovascular age-related macular degeneration (nAMD), could save the NHS millions
- Published: 16 June 2019
Treatments for broken bones
The NIHR-funded WOLLF study set out to find the best wound dressing for open fractures.
- Published: 16 June 2019
Improving safety for people who inject drugs
NIHR researchers worked with people who inject drugs to understand their views on new, safer equipment, helping to increase the adoption across the UK.
- Published: 15 June 2019
Virtual reality for mental health
Case study on research into new technology for mental health disorders
- Published: 14 June 2019
Improving treatment for advanced prostate cancer
NIHR-supported trial, STAMPEDE, set out find the best way of treating men with high risk prostate cancer by assessing the effect of a range of new treatments.
- Published: 14 June 2019
New independence for people with neurodegenerative diseases
The NIHR funds the development and testing of novel medical technologies that can change the lives of patients
- Published: 12 June 2019
Beating the bugs
The NIHR has committed over £100 million into research addressing the use of antimicrobial drugs such as antibiotics to help tackle antimicrobial resistance.
- Published: 02 April 2019
Living well with dementia
The IDEAL study the first large-scale project of its kind to investigate what factors can be targeted to support people to live well with dementia.
- Published: 02 April 2019
Treating multiple myeloma
NIHR research into myeloma includes clinical trials testing innovative new drugs which may have therapeutic benefit for patients.
- Published: 02 April 2019
Curing the most common form of blindness
Case study on research into treatments for age-related macular degeneration
- Published: 02 April 2019